Belgian Banks Stock News

Why the latest guidance update matters for ageas stock ageas (ENXTBR:AGS) has drawn fresh attention after raising its full year 2026 net operating result guidance to above €1.95b and confirming an interim dividend of €1.5 per share payable in December. These updates were released alongside half year 2026 results, with net income of €846 million compared to €677 million a year earlier and higher earnings per share from continuing operations on both a basic and diluted basis. ageas shares have...

Ackermans & Van Haaren stock came into the results on a quiet winning streak, with modest gains over the past week and month, and a P/E of 13.9x that already priced in solid execution. The headline today is earnings power. Basic earnings per share for the first half printed at €10.39, feeding into trailing twelve month earnings of €20.17 per share, alongside a net profit margin of 11.1%. The market now has to decide if that earnings profile justifies treating Ackermans & Van Haaren as a cheap...

Recticel stock came into this earnings print on a strong short term run, with the price at €13.72 after solid gains over the past three months. The market has been treating it like an earnings recovery story, yet the headline from this half year is more about pressure than celebration. Revenue reached €390.143m, but net income from ongoing activity stayed modest at €9.665m. The strain from discontinued operations, which dragged earnings by €25.644m, is the core issue investors will be...

Tessenderlo Group walked into this earnings day with a slowly recovering share price and a stock still framed as a valuation story, trading at a low price to sales multiple and well below one reference fair value estimate. The headline today is that the chemicals and industrial group has put profit back on the table in H1 2026, with around €1.5b in revenue and about €66m in net income after recent losses. Love the return to profit at Tessenderlo Group but concerned it could still be a value...

ageas went into this earnings season with a stock that had quietly climbed, up about 12% over three months and closing at €74.75 on 28 August. The market had been treating it as a solid, income rich insurer with a generous yield and a low P/E. The headline from H1 2026 is different. The real story is a profit machine leaning hard on margins, with net operating result guidance now above €1.95b and a group return on equity of 15.8%. For investors, the gap between that valuation and those profit...

The market barely shrugged at Qrf Comm. VA this week, with the stock almost flat over seven days and trading at €10.15 into the H1 2026 release. The numbers tell a sharper story. Reported earnings look strong on paper, helped by a very large one off gain that still feeds into trailing figures and helps keep the P/E near 3.8x. For a retail focused REIT, that creates a clear expectation gap, as investors are paying a low multiple for earnings that are flattered by accounting gains rather than...

Ion Beam Applications stock closed at €16.84 after a steady run over the past quarter. The real story is not in today’s modest move. It sits in how H1 2026 earnings landed against a valuation that already prices the company at about 19.9x trailing P/E, below the wider European medical equipment group. The headline takeaway for investors is simple: Ion Beam Applications delivered €323.7m in H1 revenue with a positive net result of €9.3m, and management reiterated at least €32m in adjusted EBIT...

Cmb.Tech stock came into this earnings print with a strong recent run, up about 17% over the past three months and trading around €15.9. The quarterly headline is blunt. The shipping group reported net income of $364.38m on $703.94m of revenue in Q2 2026, supported by exceptionally rich freight markets and capital gains on vessel sales. For investors, the gap between a low 6.4x P/E and a business currently generating substantial cash is the key point to monitor. The question is how long this...

DEME Group stock came into this earnings print with a solid recent run, up about 10% over the past month and slightly higher over the past week. The market has been paying for a construction and offshore contractor that can turn complex projects into consistent cash. H1 2026 results now put numbers behind that reputation. Revenue reached a record first half level of about €2.2b, while net profit hit €215m and free cash flow came in at €231m. For an asset heavy marine contractor, this...

Exmar stock closed at €11.35, with the market still treating it like a high yielding value play that carries real questions about staying power. The new H1 2026 numbers put that tension into sharp focus. Net income of US$53.4 million and a trailing net margin of 34.5% keep the company firmly profitable, yet that margin is well below the 56.2% level seen a year earlier. For an oil and gas shipper, this squeeze in profitability, paired with a dividend yield of 7.74% that is not well covered by...

Why Tessenderlo Group’s latest half year earnings matter for the stock Tessenderlo Group (ENXTBR:TESB) has drawn fresh attention after reporting half year 2026 results that moved from a net loss to a net profit, with slightly higher sales and positive earnings per share. The upbeat half year earnings have arrived alongside a short burst of positive momentum in Tessenderlo Group’s share price, with a 1 month share price return of 5.35% and a 7 day share price return of 4.59%, even though the...

Amid recent fluctuations in the European markets, including a dip in the STOXX Europe 600 Index and declines in major indices like Germany's DAX and France's CAC 40, investors are keenly observing potential opportunities. In this environment of inflationary pressures and global bond sell-offs, identifying stocks that may be trading below their estimated intrinsic values can offer strategic entry points for those looking to capitalize on market inefficiencies.

The European market has been experiencing fluctuations, with the pan-European STOXX Europe 600 Index recently ending the week down due to global bond sell-offs and inflationary pressures. Despite these challenges, investors often seek opportunities in smaller or newer companies, where penny stocks—though an outdated term—still hold relevance as a potential investment area. These stocks can offer surprising value and growth potential when backed by solid financial foundations, making them...

Kinepolis Group NV reported past half-year earnings for the period ended June 30, 2026, with sales of €341.84 million and net income of €25.27 million, both higher than a year earlier. The jump in basic earnings per share from €0.26 to €1.13 highlights a marked improvement in profitability from the company’s continuing operations. We will now examine how this sharp earnings and profitability improvement shapes Kinepolis Group’s investment narrative and future business considerations. This...

Recent sector reports on high nickel cathode materials and black mass recycling have put Umicore (ENXTBR:UMI) back in focus for investors watching the build out of electric vehicle and circular battery supply chains. See our latest analysis for Umicore. At a share price of €23.36, Umicore has seen mixed momentum, with a 15.19% 1 month share price return and a 72.45% 1 year total shareholder return, contrasting with weaker 5 year total shareholder returns. This suggests that recent optimism...

As European markets navigate the complexities of global bond sell-offs and inflationary pressures, the pan-European STOXX Europe 600 Index recently saw a modest decline. Amidst this backdrop, growth companies with high insider ownership are drawing attention as potential indicators of strong internal confidence and alignment with shareholder interests.

As European markets navigate the complexities of global bond sell-offs and inflationary pressures, investors are increasingly looking for stability and income in the form of dividend stocks. With major indices like Germany’s DAX and France’s CAC 40 experiencing declines, identifying reliable dividend-paying stocks becomes crucial for those seeking consistent returns amid market volatility.

Roularta Media Group’s stock has been treading water, with a roughly flat 7 day return and a weaker 30 day stretch. Yet the real story now is the strain between earnings power and price. The company sits on a trailing P/E of 77.2x while net margin over the last 12 months is only 0.7%. That combination, alongside a discounted cash flow estimate of €9.85 versus a €12.35 share price at the 21 August close, sets up a clear sentiment reckoning that this earnings release brings into focus. Love the...

Deceuninck’s share price has quietly climbed over the past quarter, yet today’s reaction to fresh half year numbers looks more cautious than euphoric. Traders see a building products stock that already rerated, and then hesitate in front of the headline profit story. The key tension is margin driven earnings power. Basic earnings per share for the first half came in at €0.17 on revenue of €420.069m, while net profit over the last 12 months reached €36.537m on €809.258m of revenue. The market...

Anheuser-Busch InBev (ENXTBR:ABI) announced a US$13 million investment in its Baldwinsville, New York brewery as part of its Brewing Futures program. The funding supports new equipment at the facility and the launch of a technical skills training center for local manufacturing workers. This Baldwinsville investment forms part of Anheuser-Busch's wider US$600 million Brewing Futures initiative across its U.S. operations. This kind of manufacturing and workforce investment is not unique to...

Kinepolis Group walked into this earnings season on a strong run, with the stock up sharply over the past three months and closing at €44.8 on 20 August. That kind of rally sets a high bar, especially for a cinema operator where box office trends and operating leverage matter more than hype. The headline this time is earnings power. Basic earnings per share for the first half of 2026 came in at €1.13 on revenue of €341.843 million, confirming that profit generation, not just sentiment, is...

argenx (ENXTBR:ARGX) is back in focus after reporting that the ALKIVIA Phase 3 trial of VYVGART Hytrulo in adults with autoimmune myositis met its primary endpoint, with clinically meaningful and statistically significant improvements. See our latest analysis for argenx. The positive ALKIVIA trial update comes on top of recent momentum in argenx, with a 7 day share price return of 17.34% and a 1 year total shareholder return of 53.68%, alongside a 5 year total shareholder return above...

As European markets navigate resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently saw a slight decline, reflecting the complex landscape investors face. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to enhance their portfolios amidst fluctuating market conditions.

Why the latest FINTEPLA data matters for UCB stock UCB (ENXTBR:UCB) is in focus after new EpilepsiaOpen data on FINTEPLA in Lennox Gastaut syndrome reported sustained seizure reductions, early improvements in global functioning, and an overall acceptable long term tolerability profile. For investors tracking UCB stock, this product update raises fresh questions about how FINTEPLA fits within the group’s broader neurology portfolio and what the findings might mean for long term revenue...